H5 Central Antigen mRNA-LNP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for H5 Central Antigen mRNA-LNP, covering 2026-01-30 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of Two Doses of a Novel H5 Central Antigen mRNA-LNP in Healthy Adults [Phase 1]